Stories > Biosimilar HLX14 Succeeds in Trials

Biosimilar HLX14 Succeeds in Trials

4D Molecular Therapeutics Raises $300 Mi...

ABBio Innovates Antibody Development

ABIONYX Pharma Files 2023 Document

ANJESO Drug Insight and Market Forecast

Acquisition Progress Amid Safety Concern

Aldeyra Therapeutics R&D Day 2024